How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the US

News Snapshot:

An official in the Department of Pharmaceuticals, which comes under the Union Ministry of Chemicals and Fertilisers, told ThePrint, “They want the government to immediately announce a complete import duty waiver on drugs coming from the US to India, so that the Trump administration does not go ahead with its plan to impose reciprocal tariff, which will be a big blow to many companies.” Multiple Indian pharma players that earn a major chunk of their revenue by exporting to the US are now lobbying for a complete duty waiver on drugs coming from the US. According to top government and...